23/01/2025  20:57:03 Var. +0.900 Volume Denaro20:57:03 Lettera20:57:03 Capitalizzazione di mercato Dividend Y. Rapporto P/E
144.950EUR +0.62% 7,726
Fatturato: 1.12 mill.
144.050Quantità in denaro: 100 144.950Quantità in lettera: 100 18.66 bill.EUR 1.52% 22.25

Descrizione business

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Belén Garijo
Consiglio di amministrazione
Helene von Roeder, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Consiglio di sorveglianza
Michael Kleinemeier, Sascha Held, Anne Lange, Dietmar Oeter, Simon Thelen, Birgit Biermann, Katja Garcia Vila, Carla Kriwet, Barbara Lambert, Stefan Palzer, Alexander Putz, Christian Raabe, Michael Reinhart, Susanne Schaffert, Sandra Schwebke, Daniel Thelen
 

Dati aziendali

Name: Merck KGaA
Indirizzo: Frankfurter Str. 250,D-64293 Darmstadt
Telefono: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 66.28%
Data dell'IPO: 20/10/1995

Rapporti con gli investitori

Name: Constantin Fest
IR telefono: +49-6151-72-3321
IR Fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Company calendar

CW 10 | 06/03/2025 Annual Report
CW 17 | 25/04/2025 General Shareholder Meeting
CW 20 | 15/05/2025 Interim Report 1st Quarter/3 Months
CW 32 | 07/08/2025 Interim Report 2nd Quarter/6 Months
CW 46 | 13/11/2025 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
73.64%
BlackRock, Inc.
 
7.43%
Massachusetts Financial Services Company
 
5.06%
Sun Life Financial Inc.
 
4.91%
FMR LLC
 
3.02%
Amundi S.A.
 
2.99%
DWS Investment GmbH
 
2.95%